Picture courtesy The Indian Express
New Delhi: The Drugs Controller General of India (DCGI) has granted emergency use authorization to the COVID-19 vaccine Covovax for 12-17 years age group, PTI reported on Wednesday quoting official sources.
Covovax, the Indian version of US-developed Novavax, is manufactured in this country by Serun Institute of India.
It is the fourth COVID vaccine to receive regulator’s nod for use among under-18 age group.
The other three are Bharat Biotech’s Covaxin, which is being used to vaccinate those aged between 15 and 18 years after getting clearance last December; Zydus Cadila’s ZyCov-D which became the first one to be cleared by DCGI for those above 12 in August 2021; Biological E’s Corbevax for 12-18 years approved last month.
DCGI gave the nod to Covovax for emergency use authorization among adults on December 28, 2021, but it’s yet to be included in India’s vaccination drive.
Bhubaneswar: Odisha Chief Minister Mohan Charan Majhi on Wednesday held a meeting with district Collectors…
Bhubaneswar: The Odisha Cabinet on Wednesday approved a new scheme “Goal for Management and Treatment…
Berhampur: A 62-year-old man and his wife were on Wednesday murdered allegedly by the husband’s…
Bhubaneswar: Sky gazers are in for a treat as the last supermoon also known as…
Bhubaneswar: The Odisha government on Wednesday decided to form an inter-ministerial committee to resolve various…
Chennai: The release of Suriya and Bobby Deol starrer highly -anticipated ‘Kanguva’ had hit uncertainty…
Mumbai: Popular comedy talk show ‘The Great Indian Kapil Show’, hosted and produced by Kapil…
Balasore: Amid reports of infighting and groupism in Biju Janata Dal (BJD) after its debacle…